Oral Session 2-17B Pediatric Hematology

[OS2-17B-5] hPSC model reveals impact of GATA1 mutation on a newly defined subpopulation leading to TAM

Yoko Nishinaka¹, Akira Niwa¹, Shiori Matsuo¹, Yasuhiro Kazuki^2,3, Yuuna Yakura², Takehiko Hiroma⁴, Tsutomu Toki⁵, Tetsushi Sakuma⁶, Takashi Yamamoto⁶, Etsuro Ito⁵, Mitsuo Oshimura², Tatsutoshi Nakahata⁷, Megumu Saito¹ (1.Clinical Application, CiRA, Kyoto Univ., Kyoto, Japan, 2.Choromosome Engineering Research Center, Tottori Univ., Tottori, Japan, 3.Biomedical Science, Regenerative Medicine and Biofunction, Tottori Univ., Tottori, Japan, 4.Perinatal Medical Center, Nagano Children's Hospital, NAgano, Japan, 5.Pediatrics, Hirosaki Univ., Hirosaki, Japan, 6.Integrated Sciences for Life, Hiroshima Univ., Hiroshima, Japan, 7.Drug Discovery Technology Development Office, CiRA, Kyoto Univ., Kyoto, Japan)